| MicroRNA in disease regulation | Lifetime | 90 | CN 25 | 99.50 |
| Cancer-related molecular mechanisms research | Lifetime | 123 | CN 49 | 99.37 |
| Circular RNAs in diseases | Lifetime | 72 | CN 36 | 99.27 |
| Extracellular vesicles in disease | Lifetime | 104 | CN 24 | 98.76 |
| COVID-19 Clinical Research Studies | Lifetime | 283 | CN 45 | 98.74 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 471 | CN 29 | 98.69 |
| Silk-based biomaterials and applications | Lifetime | 105 | CN 22 | 98.01 |
| Electrospun Nanofibers in Biomedical Applications | Lifetime | 543 | CN 170 | 98.11 |
| RNA Interference and Gene Delivery | Lifetime | 970 | CN 190 | 97.70 |
| Nanoplatforms for cancer theranostics | Lifetime | 811 | CN 536 | 97.42 |
| Drug Transport and Resistance Mechanisms | Lifetime | 824 | CN 31 | 96.92 |
| Long-Term Effects of COVID-19 | Lifetime | 875 | CN 56 | 94.61 |
| Ferroptosis and cancer prognosis | Lifetime | 682 | CN 384 | 93.91 |
| SARS-CoV-2 detection and testing | Lifetime | 957 | CN 171 | 89.57 |
| Toxoplasma gondii Research Studies | Lifetime | 854 | CN 47 | 92.33 |
| Kruppel-like factors research | Lifetime | 661 | CN 81 | 89.80 |
| MicroRNA in disease regulation | 2021-2025 | 38 | CN 21 | 99.38 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 28 | CN 14 | 98.55 |
| Cancer-related molecular mechanisms research | 2021-2025 | 154 | CN 117 | 98.53 |
| Nanoplatforms for cancer theranostics | 2021-2025 | 266 | CN 230 | 98.17 |
| Extracellular vesicles in disease | 2021-2025 | 206 | CN 127 | 96.34 |
| Circular RNAs in diseases | 2021-2025 | 181 | CN 131 | 95.86 |
| Electrospun Nanofibers in Biomedical Applications | 2021-2025 | 350 | CN 196 | 95.55 |
| Silk-based biomaterials and applications | 2021-2025 | 70 | CN 39 | 94.62 |
| Immune cells in cancer | 2021-2025 | 408 | CN 221 | 93.05 |
| RNA Interference and Gene Delivery | 2021-2025 | 378 | CN 193 | 94.31 |
| Advanced Photonic Communication Systems | 2021-2025 | 209 | CN 113 | 95.34 |
| Advanced Fiber Laser Technologies | 2021-2025 | 504 | CN 277 | 95.09 |
| Immune Cell Function and Interaction | 2021-2025 | 946 | CN 207 | 91.32 |
| Ferroptosis and cancer prognosis | 2021-2025 | 641 | CN 545 | 92.29 |
| Epigenetics and DNA Methylation | 2021-2025 | 881 | CN 332 | 90.72 |
| Immunotherapy and Immune Responses | 2021-2025 | 929 | CN 254 | 91.18 |
| Nanoparticle-Based Drug Delivery | 2021-2025 | 682 | CN 267 | 90.68 |
| Peptidase Inhibition and Analysis | 2021-2025 | 662 | CN 193 | 89.31 |
| Tissue Engineering and Regenerative Medicine | 2021-2025 | 546 | CN 167 | 86.03 |
| Endoplasmic Reticulum Stress and Disease | 2021-2025 | 783 | CN 209 | 73.98 |
| Molecular Biology Techniques and Applications | 2021-2025 | 730 | CN 197 | 72.52 |
| Nerve injury and regeneration | 2021-2025 | 754 | CN 319 | 71.37 |
| Kruppel-like factors research | 2021-2025 | 408 | CN 152 | 66.05 |
| Antimicrobial agents and applications | 2021-2025 | 655 | CN 316 | 65.48 |